[go: up one dir, main page]

SE8101205L - Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on - Google Patents

Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Info

Publication number
SE8101205L
SE8101205L SE8101205A SE8101205A SE8101205L SE 8101205 L SE8101205 L SE 8101205L SE 8101205 A SE8101205 A SE 8101205A SE 8101205 A SE8101205 A SE 8101205A SE 8101205 L SE8101205 L SE 8101205L
Authority
SE
Sweden
Prior art keywords
carbamyl
cyano
bipyridine
procedures
preparation
Prior art date
Application number
SE8101205A
Other languages
English (en)
Other versions
SE437514B (sv
Inventor
K O Gelotte
Jr C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8101205L publication Critical patent/SE8101205L/sv
Publication of SE437514B publication Critical patent/SE437514B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8101205A 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten SE437514B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
SE8101205L true SE8101205L (sv) 1981-08-27
SE437514B SE437514B (sv) 1985-03-04

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Country Status (28)

Country Link
US (1) US4264609A (sv)
JP (1) JPS56128758A (sv)
KR (2) KR840002067B1 (sv)
AR (1) AR230630A1 (sv)
AT (2) AT380237B (sv)
AU (1) AU541644B2 (sv)
BE (1) BE887663A (sv)
CA (1) CA1128523A (sv)
CH (1) CH647509A5 (sv)
DE (1) DE3107306A1 (sv)
DK (1) DK171253B1 (sv)
ES (1) ES499776A1 (sv)
FI (1) FI76787C (sv)
FR (1) FR2476646A1 (sv)
GB (1) GB2070600B (sv)
HK (1) HK71789A (sv)
IE (1) IE51696B1 (sv)
IL (1) IL62161A (sv)
IT (1) IT1210992B (sv)
LU (1) LU83169A1 (sv)
MX (1) MX6908E (sv)
NL (1) NL192109C (sv)
NO (1) NO156689C (sv)
NZ (1) NZ196282A (sv)
PH (2) PH19904A (sv)
PT (1) PT72573B (sv)
SE (2) SE437514B (sv)
ZA (1) ZA811124B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
PT72573A (pt) 1981-03-01
DK83981A (da) 1981-08-27
GB2070600B (en) 1984-07-11
IT1210992B (it) 1989-09-29
MX6908E (es) 1986-11-07
ZA811124B (en) 1982-03-31
IT8119952A0 (it) 1981-02-24
ATA305683A (de) 1985-09-15
FR2476646A1 (fr) 1981-08-28
JPS56128758A (en) 1981-10-08
IE810397L (en) 1981-08-26
GB2070600A (en) 1981-09-09
FI76787C (sv) 1988-12-12
SE452764B (sv) 1987-12-14
BE887663A (fr) 1981-08-25
LU83169A1 (fr) 1981-09-11
AU6748781A (en) 1981-09-03
AR230630A1 (es) 1984-05-31
NZ196282A (en) 1983-12-16
IL62161A0 (en) 1981-03-31
DE3107306C2 (sv) 1990-11-29
FI76787B (fi) 1988-08-31
IE51696B1 (en) 1987-02-18
NO810639L (no) 1981-08-27
FR2476646B1 (sv) 1984-08-17
DK171253B1 (da) 1996-08-12
AT380236B (de) 1986-04-25
JPH0141626B2 (sv) 1989-09-06
NL192109B (nl) 1996-10-01
CA1128523A (en) 1982-07-27
ATA88581A (de) 1985-09-15
KR830005143A (ko) 1983-08-03
DE3107306A1 (de) 1981-12-17
NL8100922A (nl) 1981-09-16
AT380237B (de) 1986-04-25
FI810582L (fi) 1981-08-27
CH647509A5 (fr) 1985-01-31
SE437514B (sv) 1985-03-04
HK71789A (en) 1989-09-14
IL62161A (en) 1984-06-29
PH17145A (en) 1984-06-04
ES499776A1 (es) 1984-06-16
AU541644B2 (en) 1985-01-17
KR840002066B1 (ko) 1984-11-09
US4264609A (en) 1981-04-28
SE8402727L (sv) 1984-05-21
KR840002067B1 (ko) 1984-11-09
NL192109C (nl) 1997-02-04
PH19904A (en) 1986-08-13
SE8402727D0 (sv) 1984-05-21
NO156689C (no) 1987-11-04
NO156689B (no) 1987-07-27
PT72573B (en) 1982-02-12

Similar Documents

Publication Publication Date Title
ES2300151T3 (es) Derivados de cianofenilo.
JP7305196B2 (ja) ハロアリルアミン類のssao/vap-1阻害剤とその用途
EP3189042B1 (en) Tetrahydroisoquinoline derived prmt5-inhibitors
ES2342240T3 (es) Derivados de isoquinolina con actividad que inhibe la angiogenia.
ES2324768T3 (es) 2,6-diamino-3,5-diciano-4-arilpiridinas sustituidas y su uso como ligandos selectivos de receptores de adenosina.
ES2294186T3 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso como ligandos selectivos del receptor de adenosina.
ES2343316T3 (es) Derivados de piridina inhibidores de la cox-2.
SE8102022L (sv) Intermediat i form av 2(ih)-pyridinoner samt forfarande for framstellning derav
GB1088531A (en) Substituted benzamides
EP0303697A1 (en) Derivatives of physiologically active substance k-252
JP7219902B2 (ja) ブルトン型チロシンキナーゼ阻害剤
JP2008517956A (ja) 二重の抗血小板性/抗凝固性ピリドキシン類似体
ES2325461T3 (es) Inhibidores de pirrolotriazina cinasa.
ES2202573T3 (es) Derivados de quinolina y de bencimidazol como antagonistas de bradiquinina.
WO2017215627A1 (zh) 手性吡咯并嘧啶化合物的制备方法
WO2020144638A1 (en) Dihydroorotate dehydrogenase inhibitors
ES8507112A1 (es) Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.
US4060601A (en) Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
US10214554B2 (en) Process for making chloro-substituted nucleoside phosphoramidate compounds
SE8101205L (sv) Nya iminiumsalter och forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on
NO832784L (no) 5-(lavere-alkyl)-1,6-nafthyridin-2(1h)-on-forbindelser og fremgangsmaate for deres fremstilling
JP2021530455A (ja) 三環式化合物
JPH11505820A5 (sv)
JP2008510701A (ja) マクロファージエラスターゼの阻害剤としての5−[3−(4−ベンジルオキシフェニルチオ)−フラ−2−イル]−イミダゾリジン−2,4−ジオン及び類似体
US4156004A (en) Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, and use

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101205-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101205-6

Format of ref document f/p: F